decrease font size
increase font size
change type face
bookmark this page
email this page
print this page
ThePoultrySite Latest News
Friday, March 02, 2007
Print This Page Intervet sees 6% global growth
THE NETHERLANDS - Revenues at Intervet increased by 3% to EUR 1,125 million boosted by strong autonomous growth of 6% across all regions and product lines.
Outpacing market growth, EBIT before incidentals increased 2% to EUR 213 million, resulting in an EBIT margin of 18.9%. Divestments and acquisitions had a negative impact on revenues of 3%.
In Europe, autonomous growth was 5%, while in North America, revenues from ongoing operations grew 12%. At the end of the year, Intervet received important product approvals for Zilmax®, a feed additive for cattle and PreveNile®, a West Nile Virus vaccine for horses.
| ThePoultrySite News Desk | More Intervet / Schering-Plough Animal Health News |
More Poultry Industry News
BIRD FLU: Egypt Announces 88th H5N1 Case
Gas, Electrical Stunning Found to be Equally Humane
Farmers' Union Supports O'Kane Turkey Growers- Tyson Foods Names New Top Executives
WTO Investigates Poultry, Livestock Complaints
Taiwanese Nutritionists Learn About DDGS- Case Continues in Poultry Litter Suit
Philippines to Import Poultry Products to Meet Demand
Innovative Egg Pasteurisation Technology Launched
Ghana Aims for Poultry Self-Sufficiency by 2012
